Ligands for PPARƔ, AR, PR and RARα activate p21 expression in cancer cells [72,106,107,158] through interactions of NR/Sp1 or NR/Sp4 with two or more members of the Sp1–6 binding sites in the proximal region of the p21 gene promoters (Figure 10). This evidence concerns the gene RARA and cancer.